These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7165965)

  • 1. The effects of sulphydryl reagents on the neutralization of LATS by human thyroid extracts.
    Shishiba Y; Ozawa Y; Shimizu T; Ohtsuki N
    Clin Endocrinol (Oxf); 1982 Sep; 17(3):207-12. PubMed ID: 7165965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subcellular localization of the long-acting thyroid stimulator inhibitor in bovine thyroid gland.
    Nitiyanant W; Dunlap D
    Endocrinology; 1978 Jul; 103(1):35-45. PubMed ID: 744082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of sulfhydryl groups in thyrotropin binding and adenylate cyclase activities of thyroid plasma membranes.
    Ozawa Y; Chopra IJ; Solomon DH; Smith F
    Endocrinology; 1979 Nov; 105(5):1221-5. PubMed ID: 226349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
    Mehdi SQ; Badger J; Kriss JP
    Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
    Yamashita K; Field JB
    J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo triiodothyronine and long acting thyroid stimulator (LATS) administration on the vitro thyroid cAMP response to thyrotrophin and LATS.
    Ikeda H; Chiu SC; Kuzuya N; Uchimura H; Nagataki S
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):193-8. PubMed ID: 6328822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).
    Wu SY; Reggio R; Florsheim W; Chopra IJ; Solomon DH
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):193-200. PubMed ID: 3825441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human thyroid-stimulating hormone and immunoglobulins on adenylate cyclase activity and the accumulation of cyclic AMP in human thyroid membranes and slices.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1978 Oct; 79(1):121-30. PubMed ID: 213523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On incubation of long acting thyroid stimulator with human thyroid and adrenal homogenates.
    Dandona P; El Kabir DJ
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):379-83. PubMed ID: 6247108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for separation of long-acting thyroid stimulator (LATS) from sera containing LATS and TSH.
    Ochi Y; Hachiya T; Yoshimura M; Miyazaki T
    Metabolism; 1977 Jul; 26(7):773-9. PubMed ID: 865284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of LATS, TSH and cholera toxin on the thyroid gland in nude mice.
    Ochi Y; Hachiya T; Miyazaki T; Kajita Y; Yoshimura M
    Endocrinol Jpn; 1977 Jun; 24(3):277-9. PubMed ID: 913337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.
    Field JB; Remer A; Bloom G; Kriss JP
    J Clin Invest; 1968 Jul; 47(7):1553-60. PubMed ID: 5658587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of thyrotrophin to low molecular weight fragments of human thyroid membranes.
    Adlkofer F; Kotulla P; Schleusener H
    Acta Endocrinol (Copenh); 1980 May; 94(1):58-63. PubMed ID: 6247874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.
    Ikeda H; Chiu SC; Kuzuya N; Uchimura H; Nagataki S
    J Endocrinol Invest; 1984 Feb; 7(1):1-6. PubMed ID: 6325527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the mouse thyrotrophin receptor with thyrotrophin binding inhibitor immunoglobulins.
    Luttrell BM
    J Endocrinol; 1983 Mar; 96(3):481-8. PubMed ID: 6131925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
    Kendall-Taylor P
    Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cyclic nucleotides of rat thyroid by chronic administration of LATS and TSH.
    Ochi Y; Hosoda S; Hachiya T; Kajita Y; Yoshimura M; Miyazaki T
    Acta Endocrinol (Copenh); 1978 Aug; 88(4):713-20. PubMed ID: 210609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.